Cargando…
Case report: A rare case of neutropenia caused by pembrolizumab in squamous lung cancer and literature review
BACKGROUND: Immune checkpoint inhibitors, including anti-PD-1 therapies, have prolonged overall survival in patients with a variety of cancers, and immunotherapy is sometimes associated with immune-related adverse events (irAEs); however, hematological toxicity, especially neutropenia, is rare. CASE...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732564/ https://www.ncbi.nlm.nih.gov/pubmed/36505877 http://dx.doi.org/10.3389/fonc.2022.973421 |